Optogenetic Therapy Offers Hope for Patients With Inherited Blindness

TUESDAY, Oct. 13, 2026-- Intravitreal administration of a ChrimsonR-expressing adeno-associated viral (AAV) vector targeting retinal ganglion cells combined with use of light-stimulating goggles seems safe for patients with blindness due to...